Effects of the MMR vaccination on the epidemiology of mumps in Germany;Effekte der Masern-Mumps-Röteln (MMR)-Impfung auf die Epidemiologie von Mumps in Deutschland

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 56, Issue 9, 2013, Pages 1305-1312

  Koch, J ^a   Takla, A ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Epidemic parotitis; Epidemiology; Germany; MMR vaccination; Mumps

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; DISEASE ERADICATION; ENDEMIC DISEASE; GERMANY; HUMAN; MASS IMMUNIZATION; METHODOLOGY; MUMPS; PREVALENCE; RISK FACTOR; STATISTICS; TREATMENT OUTCOME;

DISEASE ERADICATION; ENDEMIC DISEASES; GERMANY; HUMANS; MASS VACCINATION; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84884256463     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-013-1784-4     Document Type: Article

References (27)

1. Rubin S, Plotkin SA (2013) Mumps vaccine. In: Plotkin SA, Orenstein WA, Offit PA (Hrsg) Vaccines, 6. Aufl. Saunders, Philadelphia, S 441-469
2. Heymann D (Hrsg) Control of communicable diseases manual, 19. Aufl. American Public Health Association, Washington, S 746
3. Hviid A, Rubin S, Mühlemann K (2008) Mumps. Lancet 371:932-944
4. Bjorvatn B, Skoldenberg B (1978) Mumps and its complications in Stockholm. Br Med J 1(6115):788
5. Gupta RK, Best J, MacMahon E (2005) Mumps and the UK epidemic. BMJ 330:1132-1135
6. Russell RR, Donald JC (1958) The neurological complications of mumps. Br Med J 2:27-30
7. WHO (2007) Mumps virus vaccines. WHO position paper. Wkly Epidemiol Rec 82(7):51-60
8. Dayan GH, Rubin S (2008) Mumps outbreaks in vaccinated populations: Are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis 47(11):1458-1467
9. Otto W et al (2010) Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010. Euro Surveill 15(50
10. Hilleman MR et al (1968) Live, attenuated mumps-virus vaccine. N Engl J Med 278(5):227-232
11. WHO (2013) Countries using mumps vaccine in national immunization schedule 2011. http://www.who.int/immunization-monitoring/diseases/Mumps-map- schedule.jpg
12. RKI (2012) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Stand: Juli 2012. Epidemiol Bull 30:283-309
13. Reiter S, Poethko-Muller C (2009) Current vaccination coverage and immunization gaps of children and adolescents in Germany. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 52(11):1037-1044
14. RKI (2012) Impfquoten bei den Schuleingangsuntersuchungen in Deutschland 2010. Epidemiol Bull 16:135-139
15. Davidkin I et al (2010) MMR vaccination and disease elimination: the Finnish experience. Expert Rev Vaccines 9(9):1045-1053
16. Peltola H et al (1994) The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 331(21):1397-1402
17. Peltola H et al (2000) Mumps and rubella eliminated from Finland. JAMA 284(20):2643-2647
18. WHO Europe (1998) Health 21. The health for all policy framework for the WHO European Region. http://www.euro.who.int/-data/assets/pdf-file/0010/98398/ wa540ga199heeng.pdf
19. Pöhn HP, Rasch G (1994) Statistik meldepflichtiger übertragbarer Krankheiten. Schriftenreihe des Bundesgesundheitsamtes 5. Medizin Verlag, München
20. Gesetz zur Verhütung und Bekämpfung übertragbarer Krankheiten beim Menschen. Bundes-Seuchengesetz, in Juris FNA 2126-12000
21. Krause G et al (2007) SurvNet electronic surveillance system for infectious disease outbreaks, Germany. Emerg Infect Dis 13(10):1548-1555
22. RKI (2009) Krankheiten, für die gemäß LVO eine erweiterte Meldepflicht zusätzlich zum IfSG besteht. Epidemiol Bull 5:33-49
23. RKI (2012) Mumpsausbruch an einer Grundschule in Nürnberg 2011 - Exemplarische Beschreibung des Ausbruchsmanagements und geplante Änderung der STIKO-Empfehlung zur beruflich indizierten Mumpsimpfung. Epidemiol Bull 22:205-211
24. Poethko-Müller C, Mankertz A (2012) Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity. PLoS One 7(8):e42867
25. Kurth BM et al (2008) The challenge of comprehensively mapping children's health in a nation-wide health survey: design of the German KiGGS-Study. BMC Public Health 8:196
26. Poethko-Müller C, Kuhnert R, Schlaud M (2007) Durchimpfung und Determinanten des Impfstatus in Deutschland. Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 50:851-862
27. Ogbuanu IU et al (2012) Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak. Pediatrics 130(6):e1567-e1574